| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faba5e40fc9082aaa46b83c86ac385f5 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 |
| filingDate |
2015-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66117f2c144d97c364d9089946e4fe64 |
| publicationDate |
2017-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2017088584-A |
| titleOfInvention |
Pharmaceutical composition |
| abstract |
An object of the present invention is to provide a pharmaceutical composition effective for the treatment of a novel depression with few side effects such as increase / decrease in body weight, decrease in appetite and decrease in libido and symptoms of withdrawal. A pharmaceutical composition for treating depression comprising a muscle relaxant. [Selection] Figure 1 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7257091-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020262317-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2020262317-A1 |
| priorityDate |
2015-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |